US 11786518
Ophthalmic formulations and uses thereof
granted A61KA61K31/47A61K47/40
Quick answer
US patent 11786518 (Ophthalmic formulations and uses thereof) held by Aldeyra Therapeutics, Inc. expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aldeyra Therapeutics, Inc.
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/47, A61K47/40, A61K9/0048, A61K9/08